TechGenyz
Author at TechGenyz Health

World’s biggest COVID-19 vaccination program set to begin in India: PM

Prime Minister Narendra Modi said on Monday that the world’s biggest inoculation drive against coronavirus is set to begin in the country, a day after the drugs regulator approved two vaccines for restricted emergency use.

Lauding the scientists and technicians for the ‘Made in India’ vaccines, he said that the country is proud of them.

World’s biggest COVID-19 vaccination programme set to begin in India. For this, the country is proud of the contributions of its scientists and technicians- said Modi.

On Sunday, India’s drugs regulator approved Oxford COVID-19 vaccine Covishield, manufactured by the Serum Institute, and indigenously developed Covaxin of Bharat Biotech for restricted emergency use in the country, paving the way for a massive inoculation drive.

Addressing scientists at the National Metrology Conclave, Modi said it must be ensured that ‘Made in India’ products not only have global demand but also global acceptance.

Quality is as much important as quantity, our standards should rise with our scale in our quest for Aatmanirbhar Bharat– he said.

The prime minister said that research is key and effective in any progressive society, and its effects are commercial and social. They also help widen approach and thinking.

Past teaches us that more a country concentrates on science, the more its technology gets strengthened. This technology in turn helps new industries and promotes research. This cycle takes the country ahead- he said.

We do not want to fill the world with Indian products, but we must win the hearts of every customer of Indian products in every corner of the world- he said.

Quality of services in our country and products, both public or private sector, will determine India’s strength in the world, he stressed.

Affiliate Disclosure: We may receive commision from the purchase made via the affiliate links placed on this page. We have a consistent editorial voice and the commission we receive does not influence our editorial policy, the content or topics. Please read our disclosure policy for more details.